Matthew Parris
Technik-/Wissenschafts-/F&E-Leiter bei TRAWS PHARMA, INC.
Ursprung des Netzwerks ersten Grades von Matthew Parris
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 20 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Matthew Parris
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| University of Calgary | College/University | Doctorate Degree Doctorate Degree | |
Allos Therapeutics, Inc.
 Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | Pharmaceuticals: Major | Corporate Officer/Principal President | |
| Icahn School of Medicine at Mount Sinai | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
| SPECTRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Human Resources Officer | |
Translational Development Acquisition Corp.
 Translational Development Acquisition Corp. Financial ConglomeratesFinance Translational Development Acquisition Corp. is a blank check company that was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on April 19, 2022 and is headquartered in New York, NY. | Financial Conglomerates | Chief Executive Officer Director/Board Member | |
| INTERMUNE INC | Biotechnology | Sales & Marketing | |
Medexus Pharma, Inc.
 Medexus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Medexus Pharma, Inc. develops treatments for autoimmune diseases. It focuses on development and commercialization of treatments for autoimmune diseases as well as cancer. The company was founded in 2012 and is headquartered in Chicago, IL. | Pharmaceuticals: Major | Chief Executive Officer | |
| MEDEXUS PHARMACEUTICALS INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Bombay College of Pharmacy | College/University | Undergraduate Degree | |
| Panjab University Chandigarh | College/University | Graduate Degree | |
SRI International
 SRI International Miscellaneous Commercial ServicesCommercial Services SRI International provides contract research and development services. It is an independent, nonprofit research institute conducting client-sponsored research and development for government agencies, commercial businesses, foundations, and other organizations. The company was founded in 1946 and is headquartered in Menlo Park, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| University of Connecticut | College/University | Doctorate Degree | |
| The Tisch Cancer Institute at Mount Sinai | Corporate Officer/Principal | ||
| Fels Institute of Government | College/University | Director/Board Member | |
| Osmania University | College/University | Doctorate Degree | |
| Missouri State University | College/University | Undergraduate Degree | |
| Ocugen OpCo, Inc. | Director/Board Member | ||
| OCUGEN, INC. | Pharmaceuticals: Major | Director/Board Member | |
Topaz Power Group LLC
 Topaz Power Group LLC Oilfield Services/EquipmentIndustrial Services Topaz Power Group LLC owns and operates natural gas and oil-fired plants. It operates a natural gas combined cycle plant and a natural gas steam power generating facility. The company was founded in 2004 and is headquartered in Austin, Texas. | Oilfield Services/Equipment | Director/Board Member | |
Nextran
 Nextran Medical SpecialtiesHealth Technology Part of Baxter International, Inc., Nextran is an American company that develops and commercializes organ transplantation technologies. The private company is based in NJ. Nextran was acquired by Baxter Healthcare Corp. from DNX Corp. on September 27, 1995 for $18 million. | Medical Specialties | Director/Board Member | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Cernostics, Inc.
 Cernostics, Inc. Medical SpecialtiesHealth Technology Cernostics, Inc. develops and commercializes cancer diagnostic tests. Its technology is based on a systems approach to evaluating tissues via anatomic pathology and simultaneously evaluates immune, stromal, stem cell and tumor biomarkers on a single slide while preserving tissue structure. The company was founded in 2008 by Michel Nederlof and Rebecca Critchley-Thorne and is headquartered in Pittsburgh, PA. | Medical Specialties | Director/Board Member | |
| Lehigh University | College/University | Undergraduate Degree | |
Targeted Nano Therapeutics LLC
 Targeted Nano Therapeutics LLC Pharmaceuticals: MajorHealth Technology Targeted Nano Therapeutics LLC engages in drug delivery for infectious disease. The company is headquartered In Austin, TX. | Pharmaceuticals: Major | Chairman | |
| ANTARES PHARMA, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Influmedix, Inc.
 Influmedix, Inc. Pharmaceuticals: MajorHealth Technology Influmedix, Inc. develops treatment for the control of seasonal influenza epidemics as well as pandemic influenza. The firm also focus on treatment of the seasonal flu, a constant problem every year as well as the avian flu, which continues to represent a serious pandemic threat. The company was founded by William F. DeGrado in 2006 and is headquartered in Radnor, PA. | Pharmaceuticals: Major | Director/Board Member | |
| ARBIOS SYSTEMS, INC. | Medical Specialties | Director/Board Member | |
Zebec Therapeutics LLC
 Zebec Therapeutics LLC Pharmaceuticals: MajorHealth Technology Zebec Therapeutics LLC manufactures pharmaceutical products. The private company is based in Lewes, DE. | Pharmaceuticals: Major | Chief Executive Officer | |
| VIATAR CTC SOLUTIONS INC. | Medical Specialties | Director/Board Member | |
PDI, Inc.
 PDI, Inc. Commercial Printing/FormsCommercial Services PDI, Inc. provides format printing services. It specializes in document management, electronic pre-media and on-site prepress management, to offset and full-color variable digital print, bindery, multimedia and internet services. The company was founded in February 2007 and is headquartered in Kirkland, Canada. | Commercial Printing/Forms | Director/Board Member | |
Quadrant Pharmaceuticals LLC
 Quadrant Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Quadrant Pharmaceuticals LLC manufactures pharmaceutical products. The private company is based in New York, NY. The company was founded by Jack E. Stover. | Pharmaceuticals: Major | Founder | |
| NORTHVIEW ACQUISITION CORPORATION | Financial Conglomerates | Founder | |
| PHARMACYTE BIOTECH, INC. | Pharmaceuticals: Other | Director/Board Member | |
| University of Illinois | College/University | Doctorate Degree | |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
| Princeton University | College/University | Corporate Officer/Principal | |
| University of Central Missouri | College/University | Graduate Degree | |
CardioKine, Inc.
 CardioKine, Inc. Pharmaceuticals: MajorHealth Technology CardioKine, Inc. develops drugs and pharmaceuticals for the treatment and prevention of heart failure. The company was founded by Arthur Michael Feldman, James Mervis, Paul-Andre de Lame and Michael Juliano in 2004 and is headquartered in Pittsburgh, PA. | Pharmaceuticals: Major | Director of Finance/CFO | |
| CommBio Therapeutics Co., Ltd. | Chief Tech/Sci/R&D Officer | ||
| EISAI CO., LTD. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Bar-Ilan University | College/University | Doctorate Degree | |
OncoPep, Inc.
 OncoPep, Inc. Investment ManagersFinance OncoPep, Inc. develops immunotherapeutics to prevent the progression of cancer, prolong survival, and restore the quality of life of patients. The company?s product, PVX-410, is a multi-peptide therapeutic cancer vaccine to target specific antigens found on the surface of multiple myeloma cancer cells. Its PVX-410 is targeted for smoldering multiple myeloma, a precursor disease. The company was founded by Doris Peterkin, Joslyn Dobson, and Marc A. Cohen in 2010 and is headquartered in North Andover, MA. | Investment Managers | Corporate Officer/Principal | |
| University of Zimbabwe | College/University | Doctorate Degree | |
| Kwame Nkrumah University of Science & Technology | College/University | Undergraduate Degree | |
| The Hebrew University of Jerusalem | College/University | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 38 |
| Kanada | 4 |
| Indien | 4 |
| Israel | 3 |
| Italien | 2 |
Sektoral
| Health Technology | 23 |
| Consumer Services | 17 |
| Commercial Services | 5 |
| Finance | 4 |
| Industrial Services | 2 |
Operativ
| Director/Board Member | 72 |
| Corporate Officer/Principal | 45 |
| Undergraduate Degree | 18 |
| Independent Dir/Board Member | 15 |
| Chief Tech/Sci/R&D Officer | 14 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Michael Hoffman | 39 |
| Jack Stover | 19 |
| Viren Mehta | 17 |
| Steven Fruchtman | 11 |
| Abraham Noah Oler | 11 |
| James Marino | 10 |
| Ramesh Kumar | 10 |
| Mark Gelder | 9 |
| Peter Atadja | 7 |
| Mary Shoemaker | 7 |
| Richard C. Woodman | 7 |
| Jerome Groopman | 6 |
| E. Premkumar Reddy | 6 |
| Trafford Clarke | 5 |
| Mark Guerin | 4 |
- Börse
- Insiders
- Matthew Parris
- Unternehmensverbindungen
